1004
S. Faizi et al. / Tetrahedron 65 (2009) 998–1004
3.4.3. N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenyl-2-
From a stock solution of 10 mg/ml; 10 ml, i.e., 100 mg of the sample
propenamide: aegeline (3)
was applied to a disc. The discs were air dried and then placed on
a lawn of the test organism. The plates were incubated at 37 ꢀC for
24 h and then zones of inhibition were observed around each discs,
measured, and recorded (Table 4).
White crystalline solid; [
nm ( ): 201 (53,994), 217 (49,401), 222 (50,094), 275 (51,866); IR
a]
24 0 (c 0.010, CHCl3); UV (MeOH) lmax
D
3
(CHCl3) nmax: 3405 (m) (N–H), 3355 (m) (O–H br), 2910 (w) (ali-
phatic), 2852 (w) (aryl ether), 1665 (s) (conjugated C]C), 1692 (m)
(conjugated C]O), 1625 (s) (trans conjugation), 1512 (m) (amide II;
N–H bending), 1460 (m), 1575 (w) (benzene stretching), 1507 (w)
(C]C aryl C–H vibration), 1577 (m) (aryl C–H vibrations), 980 (m)
5. Anticancer activity
Compound (4) was tested for anticancer activity against three
NCI cancer cell lines, MCF7 (breast), NCI-H460 (lung), and SF-268
(CNS), in National Cancer Institute, National Institute of Health,
Bethesda, USA.31
(CH]CH trans), 818 (m) (para-disubstituted benzene) cmꢂ1
;
HREIMS m/z: 297.1365 [Mþ] (calcd for C18H19NO3, 297.1360),
280.1285, (C18H18NO2, MþꢂOH), 279.1283 (C18H17NO2, MþꢂH2O),
160.0777 (C10H10NO), 150.0677 (C9H10O2), 137.0617 (C8H9O2),
131.0532 (C9H7O), 103.0556 (C8H7); EIMS m/z: 297 (Mþ,
C18H19NO3), 220 (C12H14NO3), 207 (C11H13NO3), 194 (C10H12NO3),
190 (C11H12NO2), 166 (C9H12NO2), 151 (C9H11O2), 150, 148, 146
(C9H8NO), 136, 135, 107 (C7H7O), 103 (C8H7), 90 (C7H6), 77 (C6H5); dC
(125 MHz, CDCl3) 167.0, 159.3, 141.7, 134.6, 133.8, 129.8, 128.8, 127.8,
127.1, 120.0, 114.0, 73.4, 55.3, 47.6; 1H NMR data, see Table 2.
Acknowledgements
We thank Dr. Gordon Cragg and Dr. Narayanan (National Cancer
Institute, National Institute of Health, Bethesda, USA) for carrying
out the anticancer activity. One of the authors (S.Z.-U.-R.) ac-
knowledges the enabling role of the Higher Education Commission
Islamabad, Pakistan and appreciates its financial support through
Merit Scholarship Scheme for Ph.D. studies in Science and Tech-
nology (200 Scholarships).
3.4.4. N-[2-Methoxy-2-(4-methoxyphenyl)ethyl]-3-phenyl-2-
propenamide (4)
Colorless and gummy; [
nm ( ): 217 (19,965), 222 (22,915), 274 (24,559); IR (CHCl3) nmax
a]
D
24 0 (c 0.012, CHCl3); UV (MeOH) lmax
3
:
References and notes
3405 (m) (N–H), 2952 (m) (aliphatic-CH2), 1663 (s) (amide I; C]O
stretching), 1626 (s) (>C]C< conjugated with aromatic ring), 1630
(s) (trans olefinic bond), 1502 (m) (C]C), 1512 (m) (amide II; N–H
bending),1443 (w), 1500 (m) (benzene stretchings), 1112 (m) (C–O),
1. Kala, C. P. Indian J. Trad. Knowledge 2006, 5, 537–540.
2. Kesari, A. N.; Gupta, R. K.; Singh, S. K.; Diwakar, S.; Watal, G. J. Ethnopharmacol.
2006, 107, 374–379.
3. Sondhi, N.; Bhardwaj, R.; Kaur, S.; Kumar, N.; Singh, B. Plant Growth Regulate.
2008, 54, 217–224.
825 (m) (para-disubstituted benzene), 981 (s) (–HC]CH–) cmꢂ1
;
Peak matching m/z: 311.1517 (Mþ, calcd for C19H21NO3, 311.1521),
164.0792 (MþꢂC9H9NO), 135.0382 (MþꢂC10H10NO2); EIMS m/z:
311 (Mþ), 280 (MþꢂOCH3), 164 (C10H12O2), 163 (C10H11O2), 152
(C9H12O2), 151 (MþꢂC10H10NO), 135 (C9H11O), 103 (C8H7), 77
(C6H5); 1H and 13C NMR data, see Table 2.
4. Jagetia, G. C.; Venkatesh, P.; Baliga, M. S. Biol. Pharm. Bull. 2005, 28, 58–64.
5. Arul, V.; Miyazaki, S.; Dhananjayan, R. J. Ethnopharmacol. 2005, 96, 159–163.
6. Chatterjee, A.; Bose, S.; Srimany, S. K. J. Org. Chem. 1959, 24, 687–690.
7. Manandhar, M. D.; Shoeb, A.; Kapil, R. S.; Popli, S. P. Phytochemistry 1978, 17,
1814–1815.
8. Govindachari, T. R.; Premila, M. S. Phytochemistry 1983, 22, 755–757.
9. Sharma, B. R.; Rattan, R. K.; Sharma, P. Phytochemistry 1981, 20, 2606–2607.
10. Reisch, J.; Hussain, R. A.; Adesina, S. K. Pharmazie 1985, 40, 503–504.
11. Maxwell, A.; Rampersad, D. J. Nat. Prod. 1989, 52, 411–414.
12. Burke, B. A.; Parkins, H. Tetrahedron Lett. 1978, 19, 2723–2726.
13. (a) Meyers, A. I.; Hanagan, R. J.; Trefonas, L. M.; Baker, R. J. Tetrahedron 1983, 39,
1991–1999; (b) Akhmedzhanova, V. I.; Batsure´n, D.; Shakirov, R. Sh. Chem. Nat.
Compd. 1993, 29, 778–780.
3.4.5. N-[2-Ethoxy-2-(4-methoxyphenyl)ethyl]-3-phenyl-2-
propenamide (5)
White powder; UV (MeOH) lmax nm (3): 215 (12,028), 224
(12,030), 272 (12,581); IR (CHCl3) nmax: 3401 (s) (N–H), 2950 (m)
(aliphatic-CH2), 1664 (m) (amide I; C]O stretching), 1619 (m)
(>C]C< conjugated with aromatic ring), 1510 (w) (amide II; N–H
bending), 1463 (m), 1614 (m) (benzene stretchings) cmꢂ1; EIMS
m/z: 325 (Mþ, C20H23NO3), 280 (MþꢂOC2H5), 179 (C11H15O2), 165
(C10H13O2), 103 (C8H7), 77 (C6H5); dC (125 MHz, CDCl3) 165.7, 159.4,
141.1, 134.8, 131.9, 129.6, 128.7, 128.0, 127.8, 120.7, 114.0, 79.9, 64.1,
55.2, 45.6, 27.9; 1H NMR data, see Table 2.
14. Tsuge, O.; Kanemasa, S.; Matsuda, K. J. Org. Chem. 1986, 51, 1997–2004.
15. Jin, Z. Nat. Prod. Rep. 2006, 23, 464–496.
16. (a) Gant, T. G.; Meyers, A. I. Tetrahedron 1994, 50, 2297–2360 (and references
cited therein); (b) Wink, M. Nat. Prod. Commun. 2008, 3, 1205–1216.
17. Crow, W. D.; Hodgkin, J. H. Tetrahedron Lett. 1963, 4, 85–89.
18. (a) Jacobs, H. M.; Burke, B. A. Oxazole Alkaloids. In The Alkaloids; Brossi, A., Ed.;
Academic, Harcourt Brace Jovanovich: San Diego, CA, 1989; Vol. 35, pp 259–310;
(b) Cheplogoi, P. K.; Mulholland, D. A.; Coombes, P. H.; Randrianarivelojosia, M.
Phytochemistry 2008, 69, 1384–1388.
19. Marcano, D. D. C.; Hasegawa, M.; Castaldi, A. Phytochemistry 1972, 11, 1531–
1532.
3.4.6. N-[2-Acetoxy-2-(4-methoxyphenyl)ethyl]-3-phenyl-2-
propenamide (6)
20. Boyd, G. V. Oxazoles and their Benzo Derivatives. In Comprehensive Heterocyclic
Chemistry; Katritzky, A. R., Rees, C. W., Eds.; Pergamon: Oxford, 1984; Vol. 6,
pp 177–233.
21. Organic Chemistry; Morrison, R. T., Boyd, R. N., Eds.; Allyn and Bacon, Universal
Book Stall: Boston, MA, 1983; Vol. 4, p 1028.
22. Lindel, T.; Breckle, G.; Hochgu¨ rtel, M.; Volk, C.; Grube, A.; Ko¨ck, M. Tetrahedron
Lett. 2004, 45, 8149–8152.
23. Albo´nico, S. M.; Kuck, A. M.; Deulofeu, V. J. Chem. Soc. C 1967, 1327–1328.
24. Ross, S. A.; Sultana, G. N. N.; Burandt, C. L.; ElSohly, M. A.; Marais, J. P. J.;
Ferreira, D. J. Nat. Prod. 2004, 67, 88–90.
White powder; UV (MeOH) lmax nm (3): 222 (10,181), 273 (10,324),
280 (9806); IR (CHCl3) nmax: 3345 (s) (N–H), 1742 (s) (O–C]O), 1641
(s) (NH–C]O) cmꢂ1
;
EIMS m/z: 339 (Mþ, C20H21NO4), 265
(MþꢂC2H3O2ꢂCH3), 192 (C11H12O3), 160 (MþꢂC10H11O3), 149
(C9H9O2), 137 (C8H9O2), 131 (C9H7O), 103 (C8H7), 77 (C6H5); dC
(100 MHz, CDCl3) 170.5, 165.9, 159.7, 141.5, 134.7, 129.8, 129.7, 128.8,
127.9,127.8,120.2,114.0, 74.3, 55.2, 44.4, 21.2; 1H NMR data, see Table 2.
25. Ross, S. A.; Al-Azeib, M. A.; Krishnaveni, K. S.; Fronczek, F. R.; Burandt, C. L.
J. Nat. Prod. 2005, 68, 1297–1299.
26. Chatterjee, A.; Majumder, R. Indian J. Chem. 1971, 9, 763–766.
27. Sharma, B. R.; Sharma, P. Planta Med. 1981, 43, 102–103.
28. Rafael, P. O.; Diaz, P. P.; de Diaz, A. M. P. Rev. Colomb. Quim. 1994, 23, 53–62;
Chem. Abstr. 1995, 122, 286624.
29. Gschwend, H. W.; Hamdan, A. J. Org. Chem. 1975, 40, 2008–2009.
30. Meyers, A. I. J. Org. Chem. 2005, 70, 6137–6151.
4. Antimicrobial activity
4.1. Antibacterial activity
32. Bauer, A. W.; Kirby, W. M.; Sherris, J. C.; Turck, M. Am. J. Clin. Pathol. 1966, 45,
493–496.
Antibacterial activity was determined by the disc diffusion
method of Baur et al.32 using Nutrient Agar Medium. For this pur-
pose, sterile discs of 6 mm diameter filter paper were prepared.